Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gulnara N. Seitova"'
Autor:
Igor N. Lebedev, Tatyana V. Karamysheva, Eugeny A. Elisaphenko, Alexey I. Makunin, Daria I. Zhigalina, Maria E. Lopatkina, Gleb V. Drozdov, Aleksander D. Cheremnykh, Natalia B. Torkhova, Gulnara N. Seitova, Stanislav A. Vasilyev, Anna A. Kashevarova, Ludmila P. Nazarenko, Nikolay B. Rubtsov
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 1030 (2021)
Interpreting the clinical significance of small supernumerary marker chromosomes (sSMCs) in prenatal diagnosis is still an urgent problem in genetic counselling regarding the fate of a pregnancy. We present a case of prenatal diagnosis of mosaic sSMC
Externí odkaz:
https://doaj.org/article/fc2a27e1d0084a8dabf6292e7be10799
Autor:
Tatyana V. Karamysheva, Aleksander D. Cheremnykh, Gleb V. Drozdov, Alexey I. Makunin, Eugeny A. Elisaphenko, S. A. Vasilyev, Gulnara N. Seitova, Maria E. Lopatkina, Nikolay B. Rubtsov, Nazarenko Lp, Natalia B. Torkhova, Daria I. Zhigalina, A. A. Kashevarova, I. N. Lebedev
Publikováno v:
Biomedicines, Vol 9, Iss 1030, p 1030 (2021)
Biomedicines
Biomedicines; Volume 9; Issue 8; Pages: 1030
Biomedicines
Biomedicines; Volume 9; Issue 8; Pages: 1030
Interpreting the clinical significance of small supernumerary marker chromosomes (sSMCs) in prenatal diagnosis is still an urgent problem in genetic counselling regarding the fate of a pregnancy. We present a case of prenatal diagnosis of mosaic sSMC
Autor:
Irina Zh. Zhalsanova, Ekatherina G. Ravzhaeva, Anna E. Postrigan, Gulnara N. Seitova, Daria I. Zhigalina, Vasilisa Yu. Udalova, Maryana M. Danina, Ilya V. Kanivets, Nikolay A. Skryabin
Publikováno v:
International Journal of Molecular Sciences. 23:10606
Rafiq syndrome (RAFQS) is a congenital disorder of glycosylation (CDG) that is caused by mutations in the MAN1B1 gene and characterized by impaired protein and lipid glycosylation. RAFQS is characterized by a delay in intellectual and motor developme
Autor:
Elena L. Amelina, Stanislav A. Krasovsky, Nina E. Akhtyamova-Givirovskaya, Nataliya Yu. Kashirskaya, Diana I. Abdulganieva, Irina K. Asherova, Ilya E. Zilber, Liliya S. Kozyreva, Lubov M. Kudelya, Natalya D. Ponomareva, Nataliya P. Revel-Muroz, Elena M. Reutskaya, Tatiana A. Stepanenko, Gulnara N. Seitova, Olga P. Ukhanova, Olga V. Magnitskaya, Dmitry A. Kudlay, Oksana A. Markova, Elena V. Gapchenko
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0261410 (2021)
PLoS ONE
PLoS ONE
Background Patients with cystic fibrosis (CF) need costly medical care and adequate therapy with expensive medicinal products. Tigerase® is the first biosimilar of dornase alfa, developed by the lead Russian biotechnology company GENERIUM. The aim o